About Immunomic Therapeutics
Immunomic Therapeutics is a private company based in Rockville, Maryland. It has reported $104,391,532 raised in nine offerings on Form D since March 2012.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 29, 2025 | Jun 2, 2025 | $6,500,000of $16.0M target | 1 | $6.5M | EquityRule 506(b) | Form D ↗ |
| Jan 30, 2024 | Apr 10, 2024 | $3,000,000of $20.9M target | 1 | $3.0M | EquityRule 506(b) | Form D ↗ |
| Feb 18, 2020 | Feb 26, 2020amended Jan 14, 2021 | $77,728,230fully sold | 6 | $12.9M | Equity, OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| Jul 18, 2018 | Aug 3, 2018 | $314,500fully sold | 1 | $314K | EquityRule 506(b) | Form D ↗ |
| Feb 28, 2017 | Mar 15, 2017 | $4,629,750of $10.0M target | 47 | $98,505 | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Dec 28, 2013 | Apr 24, 2014amended Oct 15, 2014 | $6,755,052of $8.8M target | 56 | $120K | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Jun 12, 2013 | Jun 12, 2013 | $2,729,500of $3.0M target | 36 | $75,819 | Debt, Options06 | Form D ↗ |
| Oct 31, 2012 | Jun 12, 2013 | $1,117,500of $1.3M target | 30 | $37,250 | Debt, Options06 | Form D ↗ |
| Aug 16, 2011 | Mar 5, 2012amended Jun 12, 2013 | $1,617,000of $2.0M target | 60 | $26,950 | Equity, Options06 | Form D/A ↗1 earlier filing |
| Total, nine offerings | $104,391,532 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Immunomic Therapeutics's Form D filed Jun 2, 2025.
Earlier filings also listed Ronald Thiboutot (director, last listed Apr 2024), Michael Lack (director, last listed Apr 2024), C. Winzer (chief financial officer, last listed Apr 2024), Yang-Gon Jin (director, last listed Jan 2021), William Hearl (chief executive officer and director, last listed Jan 2021), Hyuk Joo Jee (director, last listed Jan 2021), Arlo Mcginn (director, last listed Jan 2021) and Alex Kim (director, last listed Jan 2021).